¹Ì¿ë¼ºÇü
  ¿µ»óÀÇÇаú (Radiology)
  À̺ñÀÎÈÄ°ú
  ¾È°ú
  ÀÀ±ÞÀÇÇаú
  ºñ´¢±â°ú
  Á¤Çü¿Ü°ú
  °¢ °ú ±³°ú¼­ ÇÒÀÎ



[Ä¡·á¹æ»ç¼±°ú]Cancer: Principles and Practice of Oncology, (2±Çset with CD-Rom)
 
Á¤°¡  350,000¿ø
ÆǸŰ¡°Ý  310,000¿ø
ISBN  0781748658
ÃâÆÇ»ç  Lippincott
ÀúÀÚ  VINCENT T. DEVITA
¹ßÇàÀÏ  2004/12³â
±¸¸Å¼ö·®
 
 


Acclaimed by the worldwide medical community
as¡°the ultimateauthority on cancer¡±(JAMA),
Cancer: Principles and Practice of Oncology is
now in its Seventh Edition.
This completely revised, updated classic reflects
the latest break throughs
in molecularbiology, cancer prevention,
and multimodality treatment of every cancer type.

New chapters examine molecular biologic techniques
including proteomics, genomics, targeted therapies,
RNA interference, cDNA arrays, and tissue arrays.
New sections discuss bioinformatics and
societal issues in oncology, including regulatory issues,
telemedicine, and international differences in oncology.
Coverage
also includes new information on functional
and metabolic imaging,
vaccines, and antiangiogenesis agents.

* Illustrations: 850

Part I: Molecular Biology of Cancer




1. Molecular Methods in Oncology
Section 1. Amplification Techniques
Section 2. RNA Interference
Section 3. cDNA arrays
Section 4. Tissue arrays
Section 5. Cytogenetics
Section 6. Bioinformatics

2. Genomics and Proteomics

3. Molecular Targets in Oncology
Section 1. Signal transduction systems
Section 2. Cell cycle
Section 3. Apoptosis
Section 4. Telomerase

4. Invasion and Metastases

5. Angiogenesis

6. Cancer Immunology



Part II: Principles of Oncology


7. Etiology of Cancer: Viruses
Section 1. RNA Viruses
Section 2. DNA Viruses

8. Etiology of Cancer: Chemical Factors

9. Etiology of Cancer: Tobacco

10. Etiology of Cancer: Physical Factors

11. Epidemiology of Cancer
Section 1. Epidemiologic Methods
Section 2. Cancer Statistics

12. Principles of Surgical Oncology
Section 1. General Issues
Section 2. Laparascopic Surgery

13. Principles of Radiation Oncology

14. Principles of Medical Oncology

15. Pharmacology of Cancer Chemotherapy
Section 1. Drug Development
Section 2. Pharmocokinetics
Section 3. Pharmacogenomics
Section 4. Alkylating Agents
Section 5. Cisplatin and its Analogues
Section 6. Antimetabolites
Section 7. Topoisomerase Interactive Agents
Section 8. Antimicrotubule Agents
Section 9. Miscellaneous Chemotherapeutic Agents

16. Pharmacology of Cancer Biotherapeutics
Section 1. Interferons
Section 2. Interleukin-2
Section 3. Histone Deacetyalase Inhibitors:
New Targeted Anti-cancer Drugs
Section 4. Monoclonal Antibodies

17. Pharmacology of Endocrine Manipulation

18. Design and Analysis of Clinical Trials



Part III: Practice of Oncology


19. Cancer Prevention: Preventing Tobacco-Related Cancers

20. Cancer Prevention: Diet and Chemopreventive Agents
Section 1. Dietary Fat
Section 2. Dietary Fiber
Section 3. Fruit and Vegetable Consumption
Section 4. Retinoids, Carotenoids and Micronutrients
Section 5. Dietary Carcinogens
Section 6. Cyclo-oxygenase Inhibitors
Section 7. Physical Activity and Body Weight

21. Cancer Prevention: Role of Surgery in Cancer Prevention

22. Cancer Screening

23. Advanced Molecular Diagnostics

24. Advanced Imaging Methods
Section 1. Functional and Metabolic Imaging
Section 2. Interventional Radiology

25. Cancer Diagnosis: Endoscopy
Section 1. Gastrointestinal Endoscopy
Section 2. Respiratory Tract

26. Cancer of the Head and Neck
Section 1. Molecular Biology of Head and Neck Tumors
Section 2. Treatment of Head and Neck Cancers
Section 3. Rehabilitation after Treatment for Head and Neck Cancer

27. Cancer of the Lung
Section 1. Molecular Biology of Lung Cancer
Section 2. Non small Cell Lung Cancer
Section 3. Small Cell Lung Cancer

28. Neoplasms of the Mediastinum

29. Cancers of the Gastrointestinal Tract
Section 1. Cancer of the Esophagus
Section 2. Cancer of the Stomach
Section 3. Cancer of the Pancreas
Section 4. Cancer of the Liver
Section 5. Cancer of the Biliary Tree
Section 6. Cancer of the Small Intestine
Section 7. Gastrointestinal Stromal Tumors
Section 8. Cancer of the Colon
Section 9. Cancer of the Rectum
Section 10. Cancer of the Anal Region

30. Cancers of the Genitourinary System
Section 1. Cancer of the Kidney
Section 2. Cancer of the Bladder, Ureter and Renal Pelvis
Section 3. Cancer of the Prostate
Section 4. Cancer of the Urethra and Penis

31. Cancer of the Testis

32. Gynecologic Cancers
Section 1. Cancer of the Cervix, Vagina, and Vulva
Section 2. Cancers of the Uterine Body
Section 3. Gestational Trophoblastic Diseases
Section 4. Ovarian Cancer, Fallopian Tube Carcinoma,and Peritoneal Carcinoma

33. Cancer of the Breast
Section 1. Molecular Biology of Breast Cancer
Section 2. Malignant Tumors of the Breast
Section 3. Rehabilitation After Treatment for Cancer of the Breast
34. Cancer of the Endocrine System
Section 1. Molecular Biology of Endocrine Tumors
Section 2. Thyroid Tumors
Section 3. Parathyroid Tumors
Section 4. Adrenal Tumors
Section 5. Pancreatic Endocrine Tumors
Section 6. Carcinoid Tumors and the Carcinoid Syndrome
Section 7. Multiple Endocrine Neoplasias

35. Sarcomas of the Soft Tissues and Bone
Section 1. Soft Tissue Sarcoma
Section 2. Sarcomas of Bone

36. Benign and Malignant Mesothelioma

37. Cancer of the Skin

38. Melanoma
Section 1. Molecular Biology of Cutaneous Melanoma
Section 2. Cutaneous Melanoma
Section 3. Intraocular Melanoma

39. Neoplasms of the Central Nervous System
Section 1. Molecular Biology of Central System Neoplasms
Section 2. Neoplasms of the Central Nervous System

40. Cancers of Childhood
Section 1. Molecular Biology of Childhood Cancers
Section 2. Solid Tumors of Childhood

41. Lymphomas
Section 1. Leukemias and Lymphomas of Childhood
Section 2. Non Hodgkin's Lymphomas
Section 3. Cutaneous T-Cell Lymphomas
Section 4. Primary Central Nervous System Lymphoma
Section 5. Hodgkin's Disease

42. Acute Leukemias
Section 1. Molecular Biology of Acute Leukemias
Section 2. Management of Acute Leukemias

43. Chronic Leukemias
Section 1. Chronic Myelogenous Leukemia
Section 2. Chronic Lymphoid Leukemias
Section 3. Myelodysplastic Syndromes

44. Plasma Cell Neoplasms

45. Paraneoplastic Syndromes

46. Cancer of Unknown Primary Site

47. Peritoneal Carcinomatosis

48. Immunosuppression Related Malignancies
Section 1. AIDS-Related Malignancies
Section 2. Transplantation Related Malignancies

49. Oncologic Emergencies
Section 1. Superior Vena Cava Syndrome
Section 2. Increased Intracranial Pressure
Section 3. Spinal Cord Compression
Section 4. Metabolic Emergencies
Section 5. Urologic Emergencies

50. Specialized Techniques in Cancer Management
Section 1. Vascular Access and Specialized Techniques of drug delivery
Section 2. Isolation perfusion

51. Treatment of Metastatic Cancer
Section 1. Metastatic Brain Cancer
Section 2. Metastatic Cancer to the Lung
Section 3. Metastatic Cancer to the Liver
Section 4. Metastatic Cancer to the Bone
Section 5. Malignant Pleural and Pericardial Effusions
Section 6. Malignant Ascites

52. Hematopoietic Therapy
Section 1. Transfusion Therapy
Section 2. Autologous Stem Cell Transplantation
Section 3. Allogeneic Stem Cell Transplantation
Section 4. Hematopoietic Growth Factors

53. Infections in the Cancer Patient

54. Adverse Effects of Treatment
Section 1. Nausea and Vomiting
Section 2. Oral Complications
Section 3. Pulmonary Toxicity
Section 4. Cardiac Toxicity
Section 5. Hair Loss
Section 6. Gonadal Dysfunction
Section 7. Second Cancers
Section 8. Miscellaneous Toxicities

55. Supportive Care and Quality of Life
Section 1. Management of Cancer Pain
Section 2. Nutritional Support
Section 3. Sexual Problems
Section 4. Genetic Counseling
Section 5. Psychological Issues
Section 6. Community Resources
Section 7. Specialized Care of the Terminally Ill

56. Rehabilitation of the Cancer Patient

57. Societal Issues in Oncology
Section 1. Ethical issues
Section 2. Economic issues
Section 3. Regulatory issues
Section 4. Telemedicine
Section 5. International Differences in Oncology
Section 6. The National Cancer Program

58. Information Systems in Oncology

59. Complementary, Alternative, and Integrative Therapies in Cancer Care



Part IV: Newer Approaches in Cancer Treatment


60. Gene Therapy

61. Cancer Vaccines
Section 1. Preventive Vaccines
Section 2. Therapeutic Vaccines

62. Cell Transfer Therapy

63. Antiangiogenesis Agents

64. Focused Ultrasound

65. Antisense Inhibition of Gene Expression

   
Æò°¡Á¦¸ñ µî·ÏÀÏ Æò°¡ÀÚ Á¶È¸¼ö
 »óÇ°¿¡ ´ëÇÑ Æò°¡±ÛÀÌ ¾ø½À´Ï´Ù.

   
Á¦¸ñ µî·ÏÀÏ ±Û¾´ÀÌ Q&A Á¶È¸¼ö
 »óÇ°¿¡ ´ëÇÑ ¹®ÀDZÛÀÌ ¾ø½À´Ï´Ù.